Laser prophylaxis for age-related macular degeneration

2004, Causes and prevalence of visual impairment among adults in the United States, Arch Ophthalmol, 122, 477, 10.1001/archopht.122.4.477 Leibowitz, 1980, The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975, Surv Ophthalmol, 24, 335 Sommer, 1991, Racial differences in the cause-specific prevalence of blindness in east Baltimore, N Engl J Med, 14, 1412, 10.1056/NEJM199111143252004 Klein, 1992, Prevalence of age-related maculopathy: the Beaver Dam Eye Study, Ophthalmology, 99, 933, 10.1016/S0161-6420(92)31871-8 Sorsby, 1966, The incidence and causes of blindness in England and Wales, 1948–1962 1997, Age-related macular degeneration: status ofresearch Ferris, 1983, Senile macular degeneration: review of epidemio-logic features, Am J Ophthalmol, 118, 132 Ferris, 1984, Age-related macular degeneration and blindness due to neovascular maculopathy, Arch Ophthalmol, 102, 1640, 10.1001/archopht.1984.01040031330019 1991, Argon laser photocoagulation for neovascular maculopathy after five years. Results from randomized clinical trials, Arch Ophthalmol, 109, 1109, 10.1001/archopht.1991.01080080069030 1991, Subfoveal neovascu-lar lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study, Arch Ophthalmol, 109, 1242, 10.1001/archopht.1991.01080090066027 1993, Laser photocoagulation for subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials, Arch Ophthalmol, 111, 1200, 10.1001/archopht.1993.01090090052019 1994, Laser photocoagulation for juxtafoveal choroidal neovascularization: five-year results from randomized clinical trials, Arch Ophthalmol, 112, 500, 10.1001/archopht.1994.01090160076025 1999, Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials — TAP report no. 1 [published erratum appears in Arch Ophthalmol 2000;118: 488], Arch Ophthalmol, 117, 1325 Bressler, 2001, Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials — TAP report 2, Arch Ophthalmol, 119, 198 2001, Am J Ophthalmol, 131, 541, 10.1016/S0002-9394(01)00967-9 Margherio, 2000, Laser treatments with verteporfin therapy and its potential impact on retinal practices, Retina, 20, 325, 10.1097/00006982-200004000-00001 Gragoudas, 2004, Pegaptanib for neovascular age-related macular degeneration, N Engl J Med, 351, 2805, 10.1056/NEJMoa042760 Spaide, 2005, Photodynamic therapy with verteporfin combined with intravitreal injection of tri-amcinolone acetonide for choroidal neovascularization, Ophthalmology, 112, 301, 10.1016/j.ophtha.2004.08.012 Lanchoney, 1998, A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration, Arch Ophthalmol, 116, 1045, 10.1001/archopht.116.8.1045 2001, A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8, Arch Ophthalmol, 119, 1417, 10.1001/archopht.119.10.1417 Bressler, 2003, Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11, Arch Ophthalmol, 121, 1621, 10.1001/archopht.121.11.1621 Smiddy, 1984, Prognosis of patients with bilateral macular drusen, Ophthalmology, 91, 271, 10.1016/S0161-6420(84)34309-3 Bressler, 1990, Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration, Arch Ophthalmol, 108, 1442, 10.1001/archopht.1990.01070120090035 Klein, 1997, The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study, Ophthalmology, 104, 7, 10.1016/S0161-6420(97)30368-6 Holz, 1994, Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors, Ophthalmology, 101, 1522, 10.1016/S0161-6420(94)31139-0 Gass, 1973, Drusen and disciform macular detachment and degeneration, Arch Ophthalmol, 90, 207, 10.1001/archopht.1973.01000050208006 Strahlman, 1983, The second eye of patients with senile macular degeneration, Arch Ophthalmol, 101, 1191, 10.1001/archopht.1983.01040020193003 Baun, 1993, Natural course in fellow eyes of patients with unilateral age-related exudative maculopathy: a fluorescein angiographic 4-year follow-up of 45 patients, Acta Ophthalmol, 71, 398, 10.1111/j.1755-3768.1993.tb07155.x Gass, 1971, Photocoagulation of macular lesions, Trans Am Acad Ophthalmol Otolaryngol, 75, 580 Cleasby, 1979, Prophylactic photocoagulation of the fellow eye in exudative senile maculopathy, Mod Probl Ophthalmol, 20, 141 Wetzig, 1988, Treatment of drusen-related aging macular degeneration by photocoagulation, Trans Am Ophthalmol Soc, 86, 276 Wetzig, 1994, Photocoagulation of drusen-related macular degeneration: a long-term outcome, Trans Am Ophthalmol Soc, 92, 299 Sigelman, 1991, Foveal drusen resorption one year after perifoveal laser photocoagulation, Ophthalmology, 98, 1379, 10.1016/S0161-6420(91)32122-5 Hyver, 1997, A case of visual acuity loss following laser photocoagulation for macular drusen, Arch Ophthalmol, 115, 554, 10.1001/archopht.1997.01100150556022 Duvall, 1985, Cellular mechanism of resolution of drusen after photocoagulation, Arch Ophthalmol, 103, 695, 10.1001/archopht.1985.01050050086024 Pauleikhoff, 1990, Aging changes in Bruch's membrane: a histochemical and morphologic study, Ophthalmology, 97, 171, 10.1016/S0161-6420(90)32619-2 Little, 1997, A pilot randomized controlled study of the effect of laser photocoagulation of confluent soft macular drusen, Ophthalmology, 104, 623, 10.1016/S0161-6420(97)30261-9 Figueroa, 1997, Laser photocoagulation for macular soft drusen, Retina, 17, 385, 10.1097/00006982-199717050-00004 Frennesson, 1998, Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications, Br J Ophthalmol, 82, 1169, 10.1136/bjo.82.10.1169 Bressler, 1995, Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities: Waterman study, Arch Ophthalmol, 113, 301, 10.1001/archopht.1995.01100030055022 Javornik, 1992, Changes in drusen and RPE abnormalities in age-related macular degeneration [abstract], Invest Ophthalmol Vis Sci, 33, 1230 Ho, 1997, The Choroidal Neovascularization Prevention Trial (CNVPT): assessment of macular risk factors for CNV through 1 year [abstract], Invest Ophthalmol Vis Sci, 38, S17 Glaser, 1985, Retinal pigment epithelial cells release an inhibitor of neovasculariza-tion, Arch Ophthalmol, 103, 1870, 10.1001/archopht.1985.01050120104029 Patz, 1988, Discussion. Trans Am Ophthalmol Soc 1988;92:289. Discussion of: Wetzig PC. Treatment of drusen-related aging macular degeneration by photocoagulation, Trans Am Ophthalmol Soc, 86, 276 Matsumoto, 1994, Increased production of transforming growth factor-beta 2 from cultured human retinal pigment epithelial cells by photocoagulation, Invest Ophthalmol Vis Sci, 35, 4245 Yoshimura, 1995, Photocoagulated human retinal pigment epithelial cells produce an inhibitor of vascular endothelial cell proliferation, Invest Ophthalmol Vis Sci, 36, 1686 Sarks, 1996, Prophylactic perifoveal laser treatment of soft drusen, Aust NZJ Ophthalmol, 24, 15, 10.1111/j.1442-9071.1996.tb01546.x Guymer, 1997, Laser treatment in subjects with high-risk clinical features of age-related macular degeneration. Posterior pole appearance and retinal function, Arch Ophthalmol, 115, 595, 10.1001/archopht.1997.01100150597004 Steinmetz, 1993, Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change, Br J Ophthalmol, 77, 549, 10.1136/bjo.77.9.549 Chen, 1992, Functional loss in age-related Bruch's membrane change with choroidal perfusion defect, Invest Ophthalmol Vis Sci, 33, 334 Ruiz-Moreno, 2003, Macular atrophy after photocoagulation of soft drusen, Retina, 23, 315, 10.1097/00006982-200306000-00005 Frennesson, 1997, Significant decrease in exudative complications after prophylactic laser treatment of soft drusen maculopathy in a randomized study [abstract], Invest Ophthalmol Vis Sci, 38, 18 Frennesson, 1995, Effects of argon (green) laser treatment of soft drusen in early age-related maculopathy: a 6-month prospective study, Br J Ophthalmol, 79, 905, 10.1136/bjo.79.10.905 Frennesson, 2003, Prophylactic laser treatment in early age-related maculopathy: an 8-year follow-up in a randomized pilot study shows a reduced incidence of exudative complications, Acta Ophthalmol Scand, 81, 449, 10.1034/j.1600-0420.2003.00143.x Olk, 1999, Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study, Ophthalmology, 106, 2082, 10.1016/S0161-6420(99)90487-6 Scorolli, 2003, Argon laser vs. subthreshold infrared (810-nm) diode laser macular grid photocoagulation in nonexudative age-related macular degeneration, Can J Ophthalmol, 38, 489, 10.1016/S0008-4182(03)80028-5 1998, Laser treatment in eyes with large drusen, Ophthalmology, 105, 11, 10.1016/S0161-6420(98)90931-9 1998, Choroidal neovascularization in the Choroidal Neo-vascularization Prevention Trial, Ophthalmology, 105, 1364, 10.1016/S0161-6420(98)98014-9 Ho, 1999, Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group, Ophthalmology, 106, 1367, 10.1016/S0161-6420(99)00735-6 Kaiser, 2001, Laser burn intensity and the risk for choroidal neovascular-ization in the CNVPT Fellow Eye Study, Arch Ophthalmol, 119, 826, 10.1001/archopht.119.6.826 2003, Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial, Ophthalmology, 110, 971, 10.1016/S0161-6420(03)00098-8 Owens, 1999, Fluorescein angiographic abnormalities after prophylactic macular photocoagulation for high-risk age-related macu-lopathy, Am J Ophthalmol, 127, 681, 10.1016/S0002-9394(99)00043-4 Owens, 2003, Prophylactic laser treatment appears to promote choroidal neovascularisation in high-risk ARM: results of an interim analysis, Eye, 17, 623, 10.1038/sj.eye.6700442 Rodanant, 2002, Predictors of drusen reduction after sub-threshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration, Am J Ophthalmol, 134, 577, 10.1016/S0002-9394(02)01691-4 Friberg, 2002, Prophylactic Treatment of Age-Related Macular Degeneration (PTAMD): update on the clinical trial [abstract], Invest Ophthalmol Vis Sci, 43 2004, The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): rationale, design and methodology, Clin Trials, 1, 91, 10.1191/1740774504cn007xx 2004, Baseline characteristics, the 25-item National Eye Institute visual functioning questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT), Ophthalmology, 111, 1307, 10.1016/j.ophtha.2003.10.031